title: Predicting success in phase III studies from phase II results: a new paradigm is needed.
authors.forename: Richard
authors.initials: R
authors.lastname: Leff
authors.forename: Michele
authors.initials: M
authors.lastname: Andrews
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents